1 | D (migalastat) | 1件: Migalastat Migalastat | 1件: D10359
D10359
| - | - | 1件: 19 19 |
2 | D Mannose | 1件: Mannose Mannose | - | - | - | 1件: 13 13 |
3 | D-a-tocopheryl PEG 1000 succinate | - | - | - | - | 1件: 299 299 |
4 | D-aspartate | - | - | - | - | 1件: 13 13 |
5 | D-BIOTIN | 1件: Biotin Biotin | 1件: D00029
D00029
| - | - | 3件: 10 10, 13, 20 |
6 | D-BIOTINA | 1件: Biotin Biotin | 1件: D00029
D00029
| - | - | 1件: 13 13 |
7 | D-CURA | - | - | - | - | 1件: 96 96 |
8 | D-Cure | - | - | - | - | 1件: 228 228 |
9 | D-Galactose | 1件: Galactose Galactose | 1件: D04291
D04291
| - | - | 1件: 222 222 |
10 | D-glucitol | 1件: Sorbitol Sorbitol | 1件: D00096
D00096
| - | - | 2件: 28 28, 299 |
11 | D-glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1) | 1件: Sorbitol Sorbitol | 1件: D00096
D00096
| - | - | 1件: 28 28 |
12 | D-glucitol, 1-deoxy-1-(methylamino)-,2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1) | 1件: Sorbitol Sorbitol | 1件: D00096
D00096
| - | - | 1件: 28 28 |
13 | D-glucose | 1件: D-glucose D-glucose | 1件: D00009
D00009
| - | - | 3件: 49 49, 86, 88 |
14 | D-IVA | - | - | - | - | 1件: 299 299 |
15 | D-methylphenidate | 1件: Methylphenidate Methylphenidate | 1件: D04999
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 84 84 |
16 | D-penicillamine | 1件: Penicillamine Penicillamine | 1件: D00496
D00496
| - | - | 1件: 171 171 |
17 | D-penicillamine 150mg | 1件: Penicillamine Penicillamine | 1件: D00496
D00496
| - | - | 1件: 171 171 |
18 | D-penicillamine 250 mg | 1件: Penicillamine Penicillamine | 1件: D00496
D00496
| - | - | 1件: 171 171 |
19 | D-Proline | 2件: D-Proline D-Proline, Proline | 1件: D00035
D00035
| - | - | 1件: 97 97 |
20 | D-Serine | 2件: D-Serine D-Serine, Serine | 1件: D00016
D00016
| - | - | 1件: 6 6 |
21 | D-serine (~2g/day) | 2件: D-Serine D-Serine, Serine | 1件: D00016
D00016
| - | - | 1件: 6 6 |
22 | D-SORBITOL | 1件: Sorbitol Sorbitol | 1件: D00096
D00096
| - | - | 1件: 10 10 |
23 | D.3.2 Product code where applicable13: | - | - | - | - | 1件: 193 193 |
24 | D.3.6.2 - dose massima specificare: giornaliera | - | - | - | - | 1件: 86 86 |
25 | D.3.6.2.1 - valore: 45 / 0.45 mg/ml | - | - | - | - | 1件: 97 97 |
26 | D.3.6.2.1 - valore: 5 o 10 mg/kg | - | - | - | - | 1件: 97 97 |
27 | D2E7 | - | - | - | - | 1件: 46 46 |
28 | D3 VitaCaps® | - | - | - | - | 2件: 96 96, 97 |
29 | D569 Tab. | - | - | - | - | 1件: 46 46 |
30 | D6-25-hydroxyvitamin D3 | 1件: Calcifediol Calcifediol | 1件: D00122
D00122
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
31 | D9421-C | - | - | - | - | 1件: 96 96 |
32 | D9421-C capsule 3 mg | - | - | - | - | 1件: 96 96 |
33 | D9421-C, 15mg | - | - | - | - | 1件: 96 96 |
34 | D9421-C, 9mg | - | - | - | - | 1件: 96 96 |
35 | DA-9701 | - | - | - | - | 1件: 6 6 |
36 | DA-9805 45mg | - | - | - | - | 1件: 6 6 |
37 | DA-9805 90mg | - | - | - | - | 1件: 6 6 |
38 | Dabigatran | 1件: Dabigatran Dabigatran | 1件: D09707
D09707
| 1件: F2 F2 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 5件: 51 51, 75, 85, 91, 124 |
39 | Dabigatran etexilate | 2件: Dabigatran Dabigatran, Dabigatran etexilate | 2件: D07144
D07144
,
D09707
| 1件: F2 F2 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 2件: 51 51, 75 |
40 | Dabrafenib | 1件: Dabrafenib Dabrafenib | 1件: D10064
D10064
| 1件: BRAF BRAF 💬 | 44件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Bladder cancer, Breast cancer, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanoma, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Renal cell carcinoma, Serotonergic synapse, Thyroid cancer, Vascular smooth muscle contraction, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 |
41 | Dabu ying pills | - | - | - | - | 1件: 76 76 |
42 | DAC | - | - | - | - | 1件: 13 13 |
43 | DAC HYP | - | - | - | - | 1件: 13 13 |
44 | DAC-HYP | - | - | - | - | 1件: 13 13 |
45 | Dacepton 5 mg/ml | - | - | - | - | 1件: 6 6 |
46 | Dacepton 5 mg/ml infuusioneste, liuos | - | - | - | - | 1件: 6 6 |
47 | DACLIZUMAB | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 8件: 13 13, 56, 60, 65, 97, 107, 283, 284 |
48 | Daclizumab (Anti-CD25 Humanized Monoclonal Antibody) | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
49 | Daclizumab High Yield Process | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
50 | DACLIZUMAB HYP | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
51 | Daclizumab HYP (DAC HYP | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
52 | Daclizumab HYP (DAC HYP) | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
53 | Daclizumab wih Greek suffix | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
54 | Daclizumab with Greek suufix | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
55 | DACORTIN | - | - | - | - | 1件: 97 97 |
56 | Dacortin ® | - | - | - | - | 1件: 46 46 |
57 | Dacortín 2,5mg | - | - | - | - | 1件: 222 222 |
58 | Dacortín 30mg | - | - | - | - | 1件: 222 222 |
59 | Dacortín 5mg | - | - | - | - | 1件: 222 222 |
60 | Daily hGH | - | - | - | - | 1件: 78 78 |
61 | Daily ingestion of Lactobacillus plantarum PS128 | 1件: Lactobacillus plantarum Lactobacillus plantarum | - | - | - | 1件: 6 6 |
62 | Daily rhGH | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 |
63 | Dalacin C | - | - | - | - | 1件: 46 46 |
64 | Dalacin C phosphate | 2件: Clindamycin Clindamycin, Phosphate ion | 1件: D00277
D00277
| - | - | 1件: 46 46 |
65 | Dalfampridine | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 4 4, 13 |
66 | Dalfampridine ER | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
67 | Dalfampridine ER, 10 Mg Oral Tablet, Extended Release | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
68 | Dalfampridine-ER 10mg | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
69 | Dalfampridine-ER 5mg | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
70 | Dalteparin | 1件: Dalteparin Dalteparin | - | - | - | 1件: 222 222 |
71 | Danazol | 1件: Danazol Danazol | 1件: D00289
D00289
| 3件: AR AR, ESR1, PGR 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 5件: 60 60, 63, 64, 65, 285 |
72 | DAND (14-Deoxyandrographolide) | - | - | - | - | 1件: 97 97 |
73 | DANICOPAN | 1件: Danicopan Danicopan | 1件: D11641
D11641
| 1件: CFD CFD 💬 | 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 1件: 62 62 |
74 | Danicopan (ALXN2040) | 1件: Danicopan Danicopan | 1件: D11641
D11641
| 1件: CFD CFD 💬 | 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 1件: 62 62 |
75 | Dantrolene | 1件: Dantrolene Dantrolene | 1件: D02347
D02347
| - | - | 2件: 13 13, 233 |
76 | Dantrolene sodium | 1件: Dantrolene Dantrolene | 1件: D02347
D02347
| - | - | 1件: 233 233 |
77 | Danzhu Fuyuan Granule | - | - | - | - | 1件: 222 222 |
78 | Dapagliflozin | 1件: Dapagliflozin Dapagliflozin | 1件: D08897
D08897
| 1件: SLC5A2 SLC5A2 💬 | - | 7件: 19 19, 49, 66, 67, 86, 88, 222 |
79 | Dapagliflozin 10 MG [Farxiga] | 1件: Dapagliflozin Dapagliflozin | 1件: D08897
D08897
| 1件: SLC5A2 SLC5A2 💬 | - | 2件: 86 86, 88 |
80 | Dapagliflozin 10mg Tab | 1件: Dapagliflozin Dapagliflozin | 1件: D08897
D08897
| 1件: SLC5A2 SLC5A2 💬 | - | 1件: 19 19 |
81 | DAPIROLIZUMAB PEGOL | 1件: Dapirolizumab pegol Dapirolizumab pegol | - | - | - | 2件: 13 13, 49 |
82 | Dapirolizumab pegol (DZP) | 1件: Dapirolizumab pegol Dapirolizumab pegol | - | - | - | 1件: 49 49 |
83 | Dapsone | 1件: Dapsone Dapsone | 1件: D00592
D00592
| - | - | 5件: 35 35, 42, 60, 84, 162 |
84 | Daraprim | 1件: Pyrimethamine Pyrimethamine | 1件: D00488
D00488
| - | - | 2件: 2 2, 4 |
85 | Daratumumab | 1件: Daratumumab Daratumumab | 1件: D10777
D10777
| 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 5件: 13 13, 28, 48, 49, 63 |
86 | Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) | 3件: Daratumumab Daratumumab, Hyaluronidase, Hyaluronidase (human recombinant) | 4件: D04455
D04455
,
D04456
,
D06604
,
D10777
| 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 28 28 |
87 | Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20) | 1件: Daratumumab Daratumumab | 1件: D10777
D10777
| 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 28 28 |
88 | Daratumumab Injection | 1件: Daratumumab Daratumumab | 1件: D10777
D10777
| 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 3件: 28 28, 49, 63 |
89 | Darifenacin | 1件: Darifenacin Darifenacin | 1件: D03654
D03654
| 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 2件: 6 6, 13 |
90 | Darifenacin (BAY79-4998) | 1件: Darifenacin Darifenacin | 1件: D03654
D03654
| 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 1件: 13 13 |
91 | Dark chocolate (85% cocoa) | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 |
92 | Darunavir | 1件: Darunavir Darunavir | 1件: D03656
D03656
| - | - | 1件: 2 2 |
93 | DARVADSTROCEL | 1件: Darvadstrocel Darvadstrocel | 1件: D11397
D11397
| - | - | 1件: 96 96 |
94 | Darvocet | - | - | - | - | 1件: 70 70 |
95 | Darzalex | 1件: Daratumumab Daratumumab | 1件: D10777
D10777
| 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 3件: 28 28, 49, 63 |
96 | DAS-001 | - | - | - | - | 1件: 11 11 |
97 | Dasatinib | 1件: Dasatinib Dasatinib | 2件: D03658
D03658
,
D06414
| 8件: ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 | 77件: Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 2件: 51 51, 85 |
98 | Dasatinib + Quercetin | 2件: Dasatinib Dasatinib, Quercetin | 2件: D03658
D03658
,
D06414
| 8件: ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 | 77件: Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 1件: 85 85 |
99 | Data collection | - | - | - | - | 1件: 65 65 |
100 | Data report | - | - | - | - | 1件: 162 162 |
101 | DaTSCAN | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 3件: 2 2, 5, 6 |
102 | DaTSCAN 74 MBq/ml solution for injection | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 6 6 |
103 | Daunorubicin | 1件: Daunorubicin Daunorubicin | 1件: D07776
D07776
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 65 65 |
104 | Davunetide | 1件: Davunetide Davunetide | 1件: D09401
D09401
| - | - | 3件: 5 5, 7, 127 |
105 | Davunetide (AL-108, NAP) | 1件: Davunetide Davunetide | 1件: D09401
D09401
| - | - | 3件: 5 5, 7, 127 |
106 | Daxdilimab | 1件: Daxdilimab Daxdilimab | 1件: D11778
D11778
| 1件: LILRA4 LILRA4 💬 | 2件: B cell receptor signaling pathway B cell receptor signaling pathway, Osteoclast differentiation 💬 | 2件: 49 49, 50 |
107 | DAZARLEX | - | - | - | - | 1件: 28 28 |
108 | Dazucorilant 150 mg | - | - | - | - | 1件: 2 2 |
109 | Dazucorilant 300 mg | - | - | - | - | 1件: 2 2 |
110 | DB adalimumab 40 mg eow | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
111 | DB adalimumab 40 mg ew | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
112 | DB289 | - | - | - | - | 1件: 65 65 |
113 | DC-TAB | - | - | - | - | 1件: 13 13 |
114 | DC158AM | - | - | - | - | 1件: 6 6 |
115 | DCCR | - | - | - | - | 1件: 193 193 |
116 | DCI | - | - | - | - | 2件: 6 6, 299 |
117 | DCI 1020 | - | - | - | - | 1件: 299 299 |
118 | DCR-1171X | - | - | - | - | 1件: 234 234 |
119 | DCR-L1360 | - | - | - | - | 1件: 234 234 |
120 | DCR-PH1 | - | - | - | - | 1件: 234 234 |
121 | DCR-PHXC | - | - | - | - | 1件: 234 234 |
122 | DDAND (14-deoxy-11,12-didehydroandrographolide) | - | - | - | - | 1件: 97 97 |
123 | DDAVP | 1件: Desmopressin Desmopressin | 1件: D00291
D00291
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 75 75, 288 |
124 | DDAVP (Desmopressin) | 1件: Desmopressin Desmopressin | 1件: D00291
D00291
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 288 288 |
125 | DDS | - | - | - | - | 1件: 90 90 |
126 | Deanol | 1件: Deanol Deanol | 1件: D07777
D07777
| - | - | 1件: 6 6 |
127 | Deanol pyroglutamate | 1件: Deanol Deanol | 1件: D07777
D07777
| - | - | 1件: 6 6 |
128 | Deaxamethasone | - | - | - | - | 1件: 28 28 |
129 | DEBRUMYL | - | - | - | - | 1件: 6 6 |
130 | Decadron | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 |
131 | Decadron Phosphate, Injectable | 1件: Phosphate ion Phosphate ion | - | - | - | 1件: 70 70 |
132 | Decitabine | 1件: Decitabine Decitabine | 1件: D03665
D03665
| 3件: DNMT1 DNMT1, DNMT3A, DNMT3B 💬 | 3件: Cysteine and methionine metabolism Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer 💬 | 2件: 60 60, 63 |
133 | Decolonization | - | - | - | - | 1件: 299 299 |
134 | Decortin | - | - | - | - | 2件: 46 46, 113 |
135 | DECORTIN (PREDNISONA) 5 MG COMPRIMIDOS | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
136 | Decortin 20 mg | - | - | - | - | 1件: 96 96 |
137 | Decortin 5 mg | - | - | - | - | 1件: 96 96 |
138 | Decortin 5mg tablets | - | - | - | - | 1件: 46 46 |
139 | Decortin H | - | - | - | - | 3件: 66 66, 97, 145 |
140 | Decortin H 1 mg | - | - | - | - | 1件: 97 97 |
141 | Decortin H 10mg | - | - | - | - | 1件: 97 97 |
142 | Decortin H 20mg | - | - | - | - | 1件: 97 97 |
143 | Decortin H 50 mg | - | - | - | - | 1件: 97 97 |
144 | Decortin H 5mg | - | - | - | - | 1件: 97 97 |
145 | Decortin® | - | - | - | - | 1件: 46 46 |
146 | Decrease Tocilizumab, Abatacept | 2件: Abatacept Abatacept, Tocilizumab | 2件: D02596
D02596
,
D03203
| 3件: CD80 CD80, CD86, IL6R 💬 | 25件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | 1件: 46 46 |
147 | Dectancyl | - | - | - | - | 1件: 81 81 |
148 | Defanyl 50 and 100 mg | - | - | - | - | 1件: 46 46 |
149 | Deferasirox | 1件: Deferasirox Deferasirox | 1件: D03669
D03669
| - | - | 3件: 254 254, 284, 286 |
150 | DEFERIPRONE | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 6件: 2 2, 6, 18, 120, 122, 233 |
151 | Deferiprone (Ferriprox) | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
152 | Deferiprone 20mg | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
153 | Deferiprone 30mg | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
154 | Deferiprone 600 mg delayed release tablet | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
155 | Deferiprone 80 mg/mL oral solution | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 120 120 |
156 | Deferiprone 80 mg/mL oral solution (Ferriprox) | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 120 120 |
157 | Deferiprone DR | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 2件: 2 2, 6 |
158 | Deferiprone oral solution | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 120 120 |
159 | Deferiprone treated | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 120 120 |
160 | Deferitazole | 1件: Deferitazole Deferitazole | 1件: D10388
D10388
| - | - | 1件: 284 284 |
161 | Deferoxamine | 1件: Deferoxamine Deferoxamine | 1件: D03670
D03670
| - | - | 2件: 284 284, 286 |
162 | DEFEROXAMINE MESILATE | 1件: Deferoxamine Deferoxamine | 1件: D03670
D03670
| - | - | 1件: 286 286 |
163 | DEFLAN*10CPR 6MG | - | - | - | - | 1件: 113 113 |
164 | Deflazacort | 1件: Deflazacort Deflazacort | 1件: D03671
D03671
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 30 30, 113 |
165 | Deflazacort 6 mg Tablets | 1件: Deflazacort Deflazacort | 1件: D03671
D03671
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 |
166 | Dehydrated Alcohol (Absolute Alcohol) BP for Injection | 1件: Ethanol Ethanol | 1件: D06542
D06542
| - | - | 1件: 279 279 |
167 | Dehydrated human amnion/chorion membrane | - | - | - | - | 1件: 269 269 |
168 | Dehydroepiandrosterone | 1件: Prasterone Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 5件: 49 49, 53, 83, 96, 113 |
169 | Dehydroepiandrosterone (DHEA) | 1件: Prasterone Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 49 49 |
170 | Dehydroepiandrosterone 100 and 400 mg | 1件: Prasterone Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 113 113 |
171 | Dehydroepiandrosterone [DHEA] | 1件: Prasterone Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 96 96 |
172 | Dekavil | - | - | - | - | 2件: 46 46, 97 |
173 | Dekristol | - | - | - | - | 2件: 13 13, 97 |
174 | Dekristol 20.000 ie | - | - | - | - | 1件: 96 96 |
175 | Dekristol 20000 IE | - | - | - | - | 1件: 13 13 |
176 | Dekristol® 400-Tabletten | - | - | - | - | 1件: 13 13 |
177 | Dekristol®-Tablette 1 (400 IE) | - | - | - | - | 1件: 13 13 |
178 | Deksmedetomidiini | - | - | - | - | 1件: 70 70 |
179 | Delayed and extended release mesalazine | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
180 | Delayed Release 6 mercaptopurine | 1件: Mercaptopurine Mercaptopurine | 2件: D00161
D00161
,
D04931
| 1件: HPRT1 HPRT1 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 1件: 96 96 |
181 | Delayed Release 6MP or Calcitriol vs. Purinethol | 1件: Calcitriol Calcitriol | 1件: D00129
D00129
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 |
182 | Deligoparin | - | - | - | - | 1件: 97 97 |
183 | Delix | - | - | - | - | 1件: 218 218 |
184 | Delmitide acetate | 1件: Acetate Acetate | - | - | - | 1件: 97 97 |
185 | Delta-9-tetrahydrocannabinol | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 3件: 8 8, 13, 36 |
186 | Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) | 2件: Cannabidiol Cannabidiol, Dronabinol | 2件: D00306
D00306
,
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 8 8 |
187 | DELTACORTENE | - | - | - | - | 2件: 43 43, 97 |
188 | Deltacortene 10 cpr 25mg | - | - | - | - | 1件: 97 97 |
189 | Deltacortene 20 cpr 5mg | - | - | - | - | 1件: 97 97 |
190 | DELTACORTENE FORTE*10CPR 25MG | - | - | - | - | 2件: 46 46, 97 |
191 | DELTACORTENE*10CPR 25MG | - | - | - | - | 1件: 84 84 |
192 | DELTACORTENE*20CPR 5MG | - | - | - | - | 3件: 49 49, 97, 113 |
193 | Deltacortril | - | - | - | - | 1件: 46 46 |
194 | Deltacortril Enteric | - | - | - | - | 1件: 46 46 |
195 | DEMESTRIL SEPTEM | - | - | - | - | 1件: 13 13 |
196 | Demineralized Bone Matrix | - | - | - | - | 1件: 70 70 |
197 | Denosumab | 1件: Denosumab Denosumab | 1件: D03684
D03684
| 1件: TNFSF11 TNFSF11 💬 | 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 8件: 46 46, 50, 70, 93, 95, 96, 274, 299 |
198 | Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand | 1件: Denosumab Denosumab | 1件: D03684
D03684
| 1件: TNFSF11 TNFSF11 💬 | 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 1件: 274 274 |
199 | Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand | 1件: Denosumab Denosumab | 1件: D03684
D03684
| 1件: TNFSF11 TNFSF11 💬 | 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 1件: 274 274 |
200 | Denufosol | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
201 | Denufosol tetrasodium (INS37217) | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
202 | Denufosol Tetrasodium (INS37217) Inhalation Solution | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
203 | Denufosol tetrasodium Inhalation Solution | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
204 | Denusomab | - | - | - | - | 1件: 274 274 |
205 | Deoxynojirimycin | 1件: Duvoglustat Duvoglustat | 1件: D09605
D09605
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
206 | Depakine | - | - | - | - | 2件: 102 102, 233 |
207 | DEPAKINE CHRONO 500 mg | - | - | - | - | 1件: 233 233 |
208 | DEPAKINE CHRONO® 500 mg | - | - | - | - | 1件: 233 233 |
209 | DEPALGOS*20+325MG 28CPR RP | - | - | - | - | 1件: 46 46 |
210 | DEPELESTAT | - | - | - | - | 1件: 299 299 |
211 | Depemedrone | - | - | - | - | 1件: 46 46 |
212 | Depemokimab | - | - | - | - | 2件: 44 44, 45 |
213 | Depleted Stem Cell Transplant | - | - | - | - | 1件: 285 285 |
214 | Depletion in CD45RA graft donor | - | - | - | - | 1件: 65 65 |
215 | Depletion of CD3/CD19 in an autologous stem cell transplant | - | - | - | - | 2件: 49 49, 51 |
216 | Depo Medrol | - | - | - | - | 1件: 46 46 |
217 | Depo-Medrol 40Mg/Ml Suspension for Injection | - | - | - | - | 1件: 70 70 |
218 | Depo-Medrone | - | - | - | - | 1件: 46 46 |
219 | DepoMedrol | - | - | - | - | 1件: 70 70 |
220 | Depot leuprolide acetate 3.75 mg | 2件: Acetate Acetate, Leuprolide | - | - | - | 1件: 51 51 |
221 | Depot tetracosactide | 1件: Tetracosactide Tetracosactide | 1件: D00284
D00284
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 83 83 |
222 | Deprakine | - | - | - | - | 1件: 256 256 |
223 | Dermoval | - | - | - | - | 2件: 35 35, 162 |
224 | Dersalazina sodica | - | - | - | - | 1件: 97 97 |
225 | Dersalazine | 1件: Dersalazine Dersalazine | - | - | - | 1件: 97 97 |
226 | Dersalazine sodium | 1件: Dersalazine Dersalazine | - | - | - | 1件: 97 97 |
227 | Dersimelagon | - | - | - | - | 2件: 51 51, 254 |
228 | DESAMETASONE | - | - | - | - | 1件: 28 28 |
229 | Descartes-08 | - | - | - | - | 1件: 11 11 |
230 | Desert Harvest Aloe Vera Capsules | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 1件: 226 226 |
231 | Desferal | 1件: Deferoxamine Deferoxamine | 1件: D03670
D03670
| - | - | 2件: 284 284, 286 |
232 | Desferasirox | - | - | - | - | 1件: 60 60 |
233 | Desferrioxamine | 1件: Deferoxamine Deferoxamine | 1件: D03670
D03670
| - | - | 2件: 51 51, 53 |
234 | Desflurane | 1件: Desflurane Desflurane | 1件: D00546
D00546
| - | - | 2件: 22 22, 296 |
235 | Desflurane anesthetics | 1件: Desflurane Desflurane | 1件: D00546
D00546
| - | - | 1件: 296 296 |
236 | Desipramine | 1件: Desipramine Desipramine | 1件: D07791
D07791
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 120 120, 156 |
237 | Desloratadine | 1件: Desloratadine Desloratadine | 1件: D03693
D03693
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
238 | Desloratadine given orally | 1件: Desloratadine Desloratadine | 1件: D03693
D03693
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
239 | Desmopressin | 1件: Desmopressin Desmopressin | 1件: D00291
D00291
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 5件: 6 6, 64, 72, 225, 288 |
240 | Desmopressin Acetat | 1件: Desmopressin Desmopressin | 1件: D00291
D00291
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 6 6 |
241 | Desmopressin acetate | 2件: Acetate Acetate, Desmopressin | 1件: D00291
D00291
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 64 64, 288 |
242 | DESMOPRESSIN ACETATE TRIHYDRATE | 2件: Acetate Acetate, Desmopressin | 1件: D00291
D00291
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 225 225 |
243 | Desmopressin intranasal | 1件: Desmopressin Desmopressin | 1件: D00291
D00291
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 72 72 |
244 | Desmopressin Oral Melt | 1件: Desmopressin Desmopressin | 1件: D00291
D00291
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 72 72 |
245 | Desmopressine | 1件: Desmopressin Desmopressin | 1件: D00291
D00291
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 225 225, 288 |
246 | Desmopressine nasal spray 10 mg/ml, flacon 60 doses | 1件: Desmopressin Desmopressin | 1件: D00291
D00291
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 225 225 |
247 | Desmotabs | - | - | - | - | 1件: 6 6 |
248 | Desmotabs® 0,2 mg Tabletten | - | - | - | - | 1件: 6 6 |
249 | Desmotabs® 0,2mg Tabletten | - | - | - | - | 1件: 6 6 |
250 | Desogestrel | 1件: Desogestrel Desogestrel | 1件: D02367
D02367
| 2件: ESR1 ESR1, PGR 💬 | 11件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 230 230 |
251 | Desoxyribonuclease | 1件: Desoxyribonuclease Desoxyribonuclease | - | - | - | 1件: 299 299 |
252 | Detemir | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
253 | Determination of drug effects through amantadine cessation | 1件: Amantadine Amantadine | 1件: D07441
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
254 | Detoxifying agents for antineoplastic treatment | - | - | - | - | 2件: 299 299, 337 |
255 | Deucravacitinib | 1件: Deucravacitinib Deucravacitinib | 1件: D11817
D11817
| 1件: TYK2 TYK2 💬 | 16件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis 💬 | 3件: 49 49, 96, 97 |
256 | Deupirfenidone | - | - | - | - | 1件: 85 85 |
257 | Deuterated Ivacaftor | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
258 | Deutetrabenazine | 1件: Deutetrabenazine Deutetrabenazine | 1件: D10701
D10701
| 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
259 | Deutetrabenazine Oral Tablet [Austedo] | 1件: Deutetrabenazine Deutetrabenazine | 1件: D10701
D10701
| 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
260 | DEUTIVACAFTOR | 1件: Deutivacaftor Deutivacaftor | 1件: D11423
D11423
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
261 | DEX284 | - | - | - | - | 1件: 85 85 |
262 | Dexametasona | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
263 | Dexametasone | - | - | - | - | 1件: 28 28 |
264 | Dexametasone Fosfato Sodico | - | - | - | - | 1件: 65 65 |
265 | Dexamethason | - | - | - | - | 4件: 13 13, 28, 46, 331 |
266 | Dexamethasone | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 22件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
267 | Dexamethasone (1 cycle) | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
268 | Dexamethasone (4 cycles) | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
269 | Dexamethasone (50mg 1dd6, 3 consecutive days/month) | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 |
270 | Dexamethasone (or equivalent) | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 257 257 |
271 | Dexamethasone 0,1 mg Tablets | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
272 | Dexamethasone 0,5mg | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 |
273 | Dexamethasone 0.5mg Tablet | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
274 | Dexamethasone 0.5mg/5ml solution | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 35 35, 162 |
275 | Dexamethasone 0.5mg/5ml solution in Mucolox™ | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 35 35, 162 |
276 | Dexamethasone 1,5 mg Tablets | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
277 | Dexamethasone 21-dihydrogen phosphate | 3件: Dexamethasone Dexamethasone, Hydrogen, Phosphate ion | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 |
278 | Dexamethasone 21-phosphate | 2件: Dexamethasone Dexamethasone, Phosphate ion | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
279 | Dexamethasone 2mg Tablets | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
280 | Dexamethasone 4 mg JENAPHARM | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 |
281 | Dexamethasone Abcur | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
282 | Dexamethasone and Rituximab | 2件: Dexamethasone Dexamethasone, Rituximab | 2件: D00292
D00292
,
D02994
| 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
283 | Dexamethasone given orally | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
284 | Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland). | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 235 235 |
285 | Dexamethasone Oral, 10 mg | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 |
286 | Dexamethasone Oral, 20 mg | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 |
287 | Dexamethasone Parotid Irrigation | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 53 53 |
288 | DEXAMETHASONE SODIUM PHOSPHATE | 2件: Dexamethasone Dexamethasone, Phosphate ion | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 65 65, 70, 96 |
289 | Dexamethasone sodium phosphate (soluzione 25mg/ml) | 2件: Dexamethasone Dexamethasone, Phosphate ion | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 |
290 | Dexamethasone sodium phosphate 250 mg/ 10 ml | 2件: Dexamethasone Dexamethasone, Phosphate ion | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
291 | Dexamethasone sodium phosphate 250 mg/10 ml solution | 2件: Dexamethasone Dexamethasone, Phosphate ion | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 |
292 | DEXAMETHASONE SODIUM PHOSPHATE PH. EUR. | 2件: Dexamethasone Dexamethasone, Phosphate ion | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 |
293 | DEXAMETHASONE SODIUM SULFATE | 3件: Dexamethasone Dexamethasone, Sodium sulfate, Sulfate ion | 2件: D00292
D00292
,
D05877
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 |
294 | Dexamethasone soduim phosphate | 2件: Dexamethasone Dexamethasone, Phosphate ion | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
295 | Dexamethasone, 40 mg | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 |
296 | Dexamethasone, procarbazine | 2件: Dexamethasone Dexamethasone, Procarbazine | 2件: D00292
D00292
,
D08423
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 |
297 | Dexaton | - | - | - | - | 1件: 28 28 |
298 | Dexchlorpheniramine | 1件: Dexchlorpheniramine Dexchlorpheniramine | 1件: D07803
D07803
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 49 |
299 | Dexdor | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 4, 6, 70 |
300 | Dexlansoprazole | 1件: Dexlansoprazole Dexlansoprazole | 1件: D08903
D08903
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 1件: 98 98 |
301 | DEXMEDETOMIDINA | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
302 | DEXMEDETOMIDINE | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 |
303 | Dexmedetomidine 1 | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 |
304 | Dexmedetomidine 2 | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 |
305 | Dexmedetomidine 3 | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 |
306 | Dexmedetomidine group | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 |
307 | Dexmedetomidine Hcl 100 Mcg/mL Inj | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 215 215 |
308 | DEXMEDETOMIDINE HYDROCHLORIDE | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 |
309 | Dexmedetomidine Hydrochloride Infusion | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
310 | Dexmedetomidine with ropivacaine | 2件: Dexmedetomidine Dexmedetomidine, Ropivacaine | 2件: D00514
D00514
,
D08490
| 8件: ADRA2A ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 |
311 | Dexpramipexole | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
312 | Dexpramipexole (dose 1) | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
313 | Dexpramipexole (dose 2) | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
314 | Dexpramipexole Dichydrochloride | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
315 | Dexpramipexole Dihydrochloride | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
316 | Dexrazoxane | 1件: Dexrazoxane Dexrazoxane | 1件: D03730
D03730
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 13 13 |
317 | Dexrazoxane (DRZ) plus Mitoxantrone (MX) | 2件: Dexrazoxane Dexrazoxane, Mitoxantrone | 2件: D03730
D03730
,
D08224
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 13 13 |
318 | Dextran | 1件: Dextran Dextran | 1件: D00060
D00060
| - | - | 4件: 2 2, 62, 96, 97 |
319 | DEXTRAN 1 FOR INJECTION | 1件: Dextran Dextran | 1件: D00060
D00060
| - | - | 1件: 97 97 |
320 | Dextran Sodium Sulfur Salt 5, Mw 5 kDa. a type of Low Molecular Weight Dextran Sulfate (LMW-DS) | 2件: Dextran Dextran, Sulfate ion | 1件: D00060
D00060
| - | - | 1件: 2 2 |
321 | DEXTRAN SULFATE SODIUM | 2件: Dextran Dextran, Sulfate ion | 1件: D00060
D00060
| - | - | 1件: 2 2 |
322 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 1件: D03742
D03742
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
323 | Dextromethorphan and Caffeine | 2件: Caffeine Caffeine, Dextromethorphan | 3件: D00528
D00528
,
D01453
,
D03742
| 17件: ADORA1 ADORA1, ADORA2A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, SIGMAR1 💬 | 37件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Huntington disease, Insulin signaling pathway, Long-term potentiation, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 78 78 |
324 | Dextromethorphan HBr and quinidine sulfate | 3件: Dextromethorphan Dextromethorphan, Quinidine, Sulfate ion | 2件: D03742
D03742
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 2 2 |
325 | DEXTROMETHORPHAN HYDROBROMIDE | 1件: Dextromethorphan Dextromethorphan | 1件: D03742
D03742
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 13 13, 46 |
326 | Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg | 3件: Dextromethorphan Dextromethorphan, Quinidine, Sulfate ion | 2件: D03742
D03742
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 2件: 2 2, 13 |
327 | Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg | 3件: Dextromethorphan Dextromethorphan, Quinidine, Sulfate ion | 2件: D03742
D03742
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 2件: 2 2, 13 |
328 | Dextromethorphan/Quinidine | 2件: Dextromethorphan Dextromethorphan, Quinidine | 2件: D03742
D03742
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
329 | Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg) | 2件: Dextromethorphan Dextromethorphan, Quinidine | 2件: D03742
D03742
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 8 8 |
330 | Dextrometorfano | 1件: Dextromethorphan Dextromethorphan | 1件: D03742
D03742
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 13 13 |
331 | DEXTROMETORFANO HIDROBROMURO | 1件: Dextromethorphan Dextromethorphan | 1件: D03742
D03742
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 13 13 |
332 | Dextrometorfano/Quinidina | 2件: Dextromethorphan Dextromethorphan, Quinidine | 2件: D03742
D03742
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
333 | Dextrose | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 4件: 60 60, 65, 70, 226 |
334 | Dextrose, 5% in Water | 2件: Dextrose, unspecified form Dextrose, unspecified form, Water | 1件: D00001
D00001
| - | - | 1件: 65 65 |
335 | Dezamizumab | 1件: Dezamizumab Dezamizumab | 1件: D11471
D11471
| 1件: APCS APCS 💬 | - | 1件: 28 28 |
336 | Dezocine | 1件: Dezocine Dezocine | 1件: D00838
D00838
| 2件: OPRK1 OPRK1, OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
337 | DF2156A | - | - | - | - | 1件: 162 162 |
338 | DFO | - | - | - | - | 3件: 46 46, 284, 286 |
339 | DFV890 | - | - | - | - | 1件: 106 106 |
340 | DGH | - | - | - | - | 1件: 78 78 |
341 | DHA | - | - | - | - | 8件: 6 6, 46, 48, 49, 94, 113, 299, 301 |
342 | DHC | - | - | - | - | 1件: 310 310 |
343 | DHEA | 1件: Prasterone Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 3件: 49 49, 86, 96 |
344 | DHEA tablet | 1件: Prasterone Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 86 86 |
345 | DI-17E6 | - | - | - | - | 1件: 51 51 |
346 | DIACEREIN | 1件: Diacerein Diacerein | 1件: D07270
D07270
| - | - | 3件: 36 36, 46, 63 |
347 | Diacerein 1% Ointment | 1件: Diacerein Diacerein | 1件: D07270
D07270
| - | - | 1件: 36 36 |
348 | Diacerin cream | - | - | - | - | 1件: 36 36 |
349 | DIACOMIT | 1件: Stiripentol Stiripentol | 1件: D05928
D05928
| - | - | 1件: 140 140 |
350 | DIACOMIT (Stiripentol) | 1件: Stiripentol Stiripentol | 1件: D05928
D05928
| - | - | 1件: 140 140 |
351 | Diagnosis of Fabry disease | - | - | - | - | 1件: 19 19 |
352 | Diammonium glycyrrhizinate enteric-coated capsule | - | - | - | - | 1件: 63 63 |
353 | Diazepam | 1件: Diazepam Diazepam | 1件: D00293
D00293
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 46 46, 155, 298 |
354 | Diazepam, melatonin | 2件: Diazepam Diazepam, Melatonin | 2件: D00293
D00293
,
D08170
| 18件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, MTNR1A, MTNR1B 💬 | 8件: Circadian entrainment Circadian entrainment, GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 46 46 |
355 | Diazoxide | 1件: Diazoxide Diazoxide | 1件: D00294
D00294
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 2件: 13 13, 193 |
356 | DIAZOXIDE CHOLINE | 2件: Choline Choline, Diazoxide | 2件: D00294
D00294
,
D07690
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 193 193 |
357 | Diazoxide choline controlled-release tablet | 2件: Choline Choline, Diazoxide | 2件: D00294
D00294
,
D07690
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 193 193 |
358 | DIBASE | - | - | - | - | 1件: 13 13 |
359 | DIBASE*IM OS 2F 1ML 300000UI/M | - | - | - | - | 1件: 46 46 |
360 | Dichloroacetate | 1件: Dichloroacetic acid Dichloroacetic acid | - | - | - | 1件: 86 86 |
361 | Dichloroacetate Sodium | 2件: Dichloroacetic acid Dichloroacetic acid, Sodium dichloroacetate | 1件: D05857
D05857
| 3件: PDK2 PDK2, PDK3, PDK4 💬 | 1件: Diabetic cardiomyopathy Diabetic cardiomyopathy 💬 | 1件: 86 86 |
362 | Dichlorphenamide | 1件: Diclofenamide Diclofenamide | 1件: D00518
D00518
| 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 | 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 114 114 |
363 | Diclofenac | 1件: Diclofenac Diclofenac | 1件: D07816
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 5件: 13 13, 34, 46, 78, 271 |
364 | Diclofenac + Omeprazole | 2件: Diclofenac Diclofenac, Omeprazole | 2件: D00455
D00455
,
D07816
| 4件: ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | 26件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
365 | Diclofenac 50 milligrams | 1件: Diclofenac Diclofenac | 1件: D07816
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 |
366 | Diclofenac Sodium | 1件: Diclofenac Diclofenac | 1件: D07816
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 34 34, 46 |
367 | Diclofenac sodium topical gel | 1件: Diclofenac Diclofenac | 1件: D07816
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 |
368 | Diclofenac SR | 1件: Diclofenac Diclofenac | 1件: D07816
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 |
369 | Diclophenac | - | - | - | - | 1件: 271 271 |
370 | DICLOXACILLIN | 1件: Dicloxacillin Dicloxacillin | 1件: D02348
D02348
| - | - | 1件: 299 299 |
371 | Dicynone | - | - | - | - | 1件: 227 227 |
372 | Didanosine | 1件: Didanosine Didanosine | 1件: D00296
D00296
| - | - | 2件: 25 25, 265 |
373 | Diet | - | - | - | - | 4件: 86 86, 97, 240, 299 |
374 | Diet 1 | - | - | - | - | 1件: 96 96 |
375 | Diet 2 | - | - | - | - | 1件: 96 96 |
376 | Diet A group | - | - | - | - | 1件: 85 85 |
377 | Diet B group | - | - | - | - | 1件: 85 85 |
378 | Diet C group | - | - | - | - | 1件: 85 85 |
379 | Dietanolamina de treprostinilo | 1件: Treprostinil Treprostinil | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
380 | Dietary Fiber Supplementation | - | - | - | - | 1件: 46 46 |
381 | Dietary Supplement for PKU patients | - | - | - | - | 1件: 240 240 |
382 | Dietary supplement omega3 fatty acids aand vitamins | - | - | - | - | 1件: 46 46 |
383 | Dietary therapy | - | - | - | - | 1件: 96 96 |
384 | Diethyl-[6-(4-hydroxycarbamoyl- phenyl carbamoyloxymethyl)-naphthalen-2-yl methyl]-ammonium chloride | 2件: Ammonium chloride Ammonium chloride, Chloride ion | 1件: D01139
D01139
| - | - | 1件: 107 107 |
385 | Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon | 2件: Ammonium chloride Ammonium chloride, Chloride ion | 1件: D01139
D01139
| - | - | 1件: 96 96 |
386 | Diethyldithiocarbamate | 1件: Ditiocarb Ditiocarb | - | - | - | 1件: 169 169 |
387 | Dietician designed diet | - | - | - | - | 1件: 96 96 |
388 | Difenidramina | - | - | - | - | 2件: 11 11, 63 |
389 | DIFENIDRAMINA CLORIDRATO | - | - | - | - | 3件: 11 11, 19, 63 |
390 | Different diets | - | - | - | - | 1件: 6 6 |
391 | Different HAART regimens | - | - | - | - | 1件: 265 265 |
392 | Diflucan | 1件: Fluconazole Fluconazole | 1件: D00322
D00322
| - | - | 1件: 96 96 |
393 | Diflunisal | 1件: Diflunisal Diflunisal | 1件: D00130
D00130
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 28 28 |
394 | Diflunisal (dolobid) | 1件: Diflunisal Diflunisal | 1件: D00130
D00130
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 28 28 |
395 | Digitoxin | 1件: Digitoxin Digitoxin | 1件: D00297
D00297
| 4件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | 18件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
396 | DIGNA P144 CREAM | - | - | - | - | 1件: 51 51 |
397 | Digoxin | 1件: Digoxin Digoxin | 1件: D00298
D00298
| 4件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | 18件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 8 8, 46, 210 |
398 | Digoxin 0.25 mg | 1件: Digoxin Digoxin | 1件: D00298
D00298
| 4件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | 18件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
399 | Dihuang | 1件: Rehmannia glutinosa root Rehmannia glutinosa root | - | - | - | 3件: 46 46, 66, 76 |
400 | Dihydroartemisinin | 1件: Artenimol Artenimol | 1件: D07362
D07362
| - | - | 1件: 49 49 |
401 | Dihydroartemisinin tablet | 1件: Artenimol Artenimol | 1件: D07362
D07362
| - | - | 1件: 49 49 |
402 | Dihydroergotoxine | 1件: Dihydroergotoxine Dihydroergotoxine | 1件: D07839
D07839
| - | - | 1件: 6 6 |
403 | Dihydroergotoxine Mesylate | 2件: Dihydroergotoxine Dihydroergotoxine, Ergoloid mesylate | 1件: D07839
D07839
| - | - | 1件: 6 6 |
404 | Dihydrogen | 1件: Hydrogen Hydrogen | - | - | - | 1件: 65 65 |
405 | DILATREND | - | - | - | - | 1件: 113 113 |
406 | Diltiazem | 1件: Diltiazem Diltiazem | 1件: D07845
D07845
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 51 51, 58, 86 |
407 | Diltiazem Gel 2% | 1件: Diltiazem Diltiazem | 1件: D07845
D07845
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 51 51 |
408 | Diltiazem Hydrochloride | 1件: Diltiazem Diltiazem | 1件: D07845
D07845
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
409 | Dimebon | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
410 | Dimebon (latrepirdine) | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
411 | Dimebon + Dextromethorphan | 2件: Dextromethorphan Dextromethorphan, Latrepirdine | 2件: D03742
D03742
,
D09917
| 7件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
412 | Dimebon + Ketoconazole | 2件: Ketoconazole Ketoconazole, Latrepirdine | 2件: D00351
D00351
,
D09917
| 7件: ACHE ACHE, CYP17A1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 28件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Pathways of neurodegeneration - multiple diseases, Prion disease, Prolactin signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Steroid hormone biosynthesis, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
413 | Dimebon + Omeprazole | 2件: Latrepirdine Latrepirdine, Omeprazole | 2件: D00455
D00455
,
D09917
| 8件: ACHE ACHE, ATP4A, ATP4B, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 26件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
414 | Dimebon alone | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
415 | Dimebon Dihydrochloride | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
416 | Dimebon IR | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
417 | Dimebon IR Tablet | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
418 | Dimebon MR1 | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
419 | Dimebon MR2 | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
420 | Dimebon MR3 | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
421 | Dimebon MR4 | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
422 | Dimebon Transdermal | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
423 | DIMENSION | 1件: Dithiopyr Dithiopyr | - | - | - | 1件: 55 55 |
424 | DIMETHYL FUMARATE | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 4件: 13 13, 51, 86, 296 |
425 | Dimethyl Fumarate (DMF) | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 3件: 13 13, 51, 86 |
426 | Dimethyl fumarate 240 mg | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 |
427 | Dimethyl fumarate [DMF] | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 |
428 | Dimethyl sulfoxide | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: D01043
D01043
| - | - | 1件: 226 226 |
429 | Dimethyl sulfoxide (DMSO) | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: D01043
D01043
| - | - | 1件: 226 226 |
430 | Dimethylfumarat | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 49 49 |
431 | DIMETIL-FUMARATO | - | - | - | - | 1件: 13 13 |
432 | Dimetilfumarato | - | - | - | - | 1件: 13 13 |
433 | Dimeythl Fumarate | - | - | - | - | 1件: 46 46 |
434 | DIMS0150 | - | - | - | - | 1件: 97 97 |
435 | Diosmin | 1件: Diosmin Diosmin | 1件: D07858
D07858
| - | - | 3件: 46 46, 97, 265 |
436 | Diosmin and Hesperidin Combination | 2件: Diosmin Diosmin, Hesperidin | 2件: D01038
D01038
,
D07858
| - | - | 1件: 46 46 |
437 | Diosminex, 500 mg, tabletki powlekane | - | - | - | - | 1件: 265 265 |
438 | Diovan | 1件: Valsartan Valsartan | 1件: D00400
D00400
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
439 | Diovan 160 mg | 1件: Valsartan Valsartan | 1件: D00400
D00400
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
440 | Diovan 40 mg | 1件: Valsartan Valsartan | 1件: D00400
D00400
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
441 | Diovan 80 mg | 1件: Valsartan Valsartan | 1件: D00400
D00400
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
442 | Diphenhydramine | 1件: Diphenhydramine Diphenhydramine | 1件: D00300
D00300
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 8件: 11 11, 13, 49, 51, 70, 86, 222, 256 |
443 | Diphenhydramine hydrochloride | 1件: Diphenhydramine Diphenhydramine | 1件: D00300
D00300
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 2件: 11 11, 49 |
444 | Diphenhydramine IV | 1件: Diphenhydramine Diphenhydramine | 1件: D00300
D00300
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
445 | Diphenydramine | - | - | - | - | 1件: 13 13 |
446 | Diphtheria toxoid | 1件: Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | - | - | - | 2件: 13 13, 46 |
447 | Dipivefrin | 1件: Dipivefrin Dipivefrin | 1件: D02349
D02349
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
448 | Dipivefrine | 1件: Dipivefrin Dipivefrin | 1件: D02349
D02349
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
449 | Dipotassium Salt | - | - | - | - | 1件: 46 46 |
450 | Dipraglurant | 1件: Dipraglurant Dipraglurant | - | - | - | 1件: 6 6 |
451 | Diprofos Depot | - | - | - | - | 1件: 46 46 |
452 | Dipyridamole | 1件: Dipyridamole Dipyridamole | 1件: D00302
D00302
| 2件: PDE4A PDE4A, PDE5A 💬 | 6件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 46 46, 49, 51, 66, 96, 224 |
453 | Dipyridamole and Amoxapine | 2件: Amoxapine Amoxapine, Dipyridamole | 2件: D00228
D00228
,
D00302
| 4件: PDE4A PDE4A, PDE5A, SLC6A2, SLC6A4 💬 | 8件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
454 | Dipyridamole Tab 25 MG | 1件: Dipyridamole Dipyridamole | 1件: D00302
D00302
| 2件: PDE4A PDE4A, PDE5A 💬 | 6件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 224 224 |
455 | Diquafosol | 1件: Diquafosol Diquafosol | - | - | - | 1件: 53 53 |
456 | Diroximel Fumarate | 1件: Diroximel fumarate Diroximel fumarate | 1件: D11154
D11154
| - | - | 1件: 13 13 |
457 | Diroximel Fumarate (DRF) | 1件: Diroximel fumarate Diroximel fumarate | 1件: D11154
D11154
| - | - | 1件: 13 13 |
458 | Dirucotide | 1件: Dirucotide Dirucotide | 1件: D09396
D09396
| - | - | 1件: 13 13 |
459 | Dirucotide acetate | 2件: Acetate Acetate, Dirucotide | 1件: D09396
D09396
| - | - | 1件: 13 13 |
460 | DISC-1459 | - | - | - | - | 1件: 254 254 |
461 | Discontinuation of disease modifying therapy | - | - | - | - | 1件: 13 13 |
462 | Discontinuation of respiratory co-therapy (azithromycin, RhDNase, or inhaled antibiotics) | 1件: Azithromycin Azithromycin | 2件: D06390
D06390
,
D07486
| - | - | 1件: 299 299 |
463 | Disease modified antirheumatic drugs or biological agents | - | - | - | - | 1件: 46 46 |
464 | Disease Modifying therapy | - | - | - | - | 1件: 13 13 |
465 | Disease modifying treatment (DMT) | - | - | - | - | 1件: 13 13 |
466 | Disease modifying treatments | - | - | - | - | 1件: 3 3 |
467 | Disease-modifying anti-rheumatic drugs | - | - | - | - | 1件: 46 46 |
468 | Disease-modifying antirheumatic drug | - | - | - | - | 1件: 46 46 |
469 | Disease-modifying antirheumatic drugs (DMARDs) | - | - | - | - | 1件: 46 46 |
470 | Disodium citrate | - | - | - | - | 1件: 245 245 |
471 | Disodium cromoglycate (DSCG) | 1件: Cromoglicic acid Cromoglicic acid | 1件: D07753
D07753
| - | - | 1件: 85 85 |
472 | Disodium Cromoglycate [cromolyn sodium] | 1件: Cromoglicic acid Cromoglicic acid | 1件: D07753
D07753
| - | - | 1件: 85 85 |
473 | Disodium Pamidronate 15mg (15mg strength) | 1件: Pamidronic acid Pamidronic acid | 1件: D07281
D07281
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 |
474 | Disodium Pyrophosphate | - | - | - | - | 1件: 166 166 |
475 | Disodiumpyrophosphate | - | - | - | - | 1件: 166 166 |
476 | Ditropan elixir | 1件: Oxybutynin Oxybutynin | 1件: D00465
D00465
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
477 | Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias) | 1件: Amiodarone Amiodarone | 1件: D02910
D02910
| 16件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 32件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 28 28 |
478 | Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus EGCG | 2件: Amiodarone Amiodarone, Epigallocatechin gallate | 1件: D02910
D02910
| 16件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 32件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 28 28 |
479 | DIURF-006 | - | - | - | - | 1件: 81 81 |
480 | Divalproex | - | - | - | - | 1件: 8 8 |
481 | Divalproex sodium | - | - | - | - | 1件: 51 51 |
482 | Divozilimab | - | - | - | - | 1件: 13 13 |
483 | Dl-3-n-butylphthalide (NBP) | 1件: Butylphthalide Butylphthalide | - | - | - | 1件: 22 22 |
484 | DLX105 | - | - | - | - | 1件: 96 96 |
485 | DM | - | - | - | - | 2件: 6 6, 8 |
486 | DM-1992 | - | - | - | - | 1件: 6 6 |
487 | DMARD | - | - | - | - | 1件: 46 46 |
488 | DMARD cessation | - | - | - | - | 1件: 46 46 |
489 | DMARD maintenance | - | - | - | - | 1件: 46 46 |
490 | DMARD Therapy | - | - | - | - | 1件: 46 46 |
491 | DMARDS | - | - | - | - | 2件: 46 46, 271 |
492 | DMARDs (disease-modifying antirheumatic drugs) | - | - | - | - | 1件: 46 46 |
493 | DMARDs (methotrexate | 1件: Methotrexate Methotrexate | 1件: D00142
D00142
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
494 | DMARDs or Biologics | - | - | - | - | 1件: 46 46 |
495 | DMPS | 1件: 2,3-Dimercapto-1-propanesulfonic acid 2,3-Dimercapto-1-propanesulfonic acid | - | - | - | 1件: 171 171 |
496 | DMSA | 1件: Succimer Succimer | 1件: D00572
D00572
| - | - | 1件: 171 171 |
497 | DMSO | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: D01043
D01043
| - | - | 1件: 226 226 |
498 | DMSO cocktail | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: D01043
D01043
| - | - | 1件: 226 226 |
499 | DMT | - | - | - | - | 1件: 13 13 |
500 | DMT continuation | - | - | - | - | 1件: 13 13 |
501 | DMX-200 | - | - | - | - | 1件: 222 222 |
502 | DNA analysis | - | - | - | - | 1件: 60 60 |
503 | DNA/GeneticTesting | - | - | - | - | 1件: 6 6 |
504 | DnaJ peptide | - | - | - | - | 1件: 46 46 |
505 | DNL151 | - | - | - | - | 1件: 6 6 |
506 | DNL151, DN0001575, DN1575 | - | - | - | - | 1件: 6 6 |
507 | DNL201 | - | - | - | - | 1件: 6 6 |
508 | DNL310 | - | - | - | - | 1件: 19 19 |
509 | DNL310 Drug Substance | - | - | - | - | 1件: 19 19 |
510 | DNL343 | - | - | - | - | 1件: 2 2 |
511 | DNL593 | - | - | - | - | 1件: 127 127 |
512 | DNL593 Sterile Lyophilisate | - | - | - | - | 1件: 127 127 |
513 | DNL747 | - | - | - | - | 1件: 2 2 |
514 | DNS-7801 (high dose) | - | - | - | - | 1件: 6 6 |
515 | DNS-7801 (low-dose) | - | - | - | - | 1件: 6 6 |
516 | Dobutamin | 1件: Dobutamine Dobutamine | 1件: D03879
D03879
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 215 215 |
517 | Dobutamine | 1件: Dobutamine Dobutamine | 1件: D03879
D03879
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 57 57, 58, 86, 215 |
518 | Dobutamine test | 1件: Dobutamine Dobutamine | 1件: D03879
D03879
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
519 | Docosahexaenoic acid | 1件: Doconexent Doconexent | - | - | - | 7件: 6 6, 49, 90, 94, 240, 299, 301 |
520 | Docosahexaenoic Acid (DHA) | 1件: Doconexent Doconexent | - | - | - | 3件: 6 6, 94, 299 |
521 | Docosahexaenoic Acid (DHA) Dietary Supplement | 1件: Doconexent Doconexent | - | - | - | 1件: 301 301 |
522 | Docosahexaenoic acid administration: 50 mg/kg/day during 12 months | 1件: Doconexent Doconexent | - | - | - | 1件: 299 299 |
523 | Docosahexanoic Acid | 1件: Doconexent Doconexent | - | - | - | 1件: 299 299 |
524 | Docosahexanoic Acid Supplement | 1件: Doconexent Doconexent | - | - | - | 1件: 299 299 |
525 | Dolasetron | 1件: Dolasetron Dolasetron | 1件: D07867
D07867
| 5件: HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 | 2件: Serotonergic synapse Serotonergic synapse, Taste transduction 💬 | 1件: 46 46 |
526 | Dolobid | - | - | - | - | 1件: 28 28 |
527 | Dolquine | - | - | - | - | 1件: 46 46 |
528 | Dolutegravir | 1件: Dolutegravir Dolutegravir | 1件: D10066
D10066
| - | - | 2件: 2 2, 265 |
529 | Dolutegravir / Lamivudine Oral Tablet | 2件: Dolutegravir Dolutegravir, Lamivudine | 2件: D00353
D00353
,
D10066
| - | - | 1件: 265 265 |
530 | Dolutegravir 50 MG | 1件: Dolutegravir Dolutegravir | 1件: D10066
D10066
| - | - | 1件: 265 265 |
531 | Dolutegravir, Abacavir and Lamivudine | 3件: Abacavir Abacavir, Dolutegravir, Lamivudine | 3件: D00353
D00353
,
D07057
,
D10066
| - | - | 1件: 2 2 |
532 | Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO] | 2件: Dolutegravir Dolutegravir, Lamivudine | 2件: D00353
D00353
,
D10066
| - | - | 1件: 265 265 |
533 | Domperidone | 1件: Domperidone Domperidone | 2件: D01745
D01745
,
D07868
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 5件: 6 6, 13, 17, 51, 230 |
534 | Domperidone (drug) | 1件: Domperidone Domperidone | 2件: D01745
D01745
,
D07868
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
535 | Dompéridone | - | - | - | - | 1件: 6 6 |
536 | Donepezil | 1件: Donepezil Donepezil | 1件: D07869
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 9件: 5 5, 6, 13, 46, 78, 124, 127, 156, 206 |
537 | Donepezil HCI (drug) | 1件: Donepezil Donepezil | 1件: D07869
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 13 13 |
538 | Donepezil Hydrochloride | 1件: Donepezil Donepezil | 1件: D07869
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 6 6, 124, 156 |
539 | Donepezil Sandoz | 1件: Donepezil Donepezil | 1件: D07869
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
540 | Donor Lymphocyte Infusion (DLI) | - | - | - | - | 1件: 60 60 |
541 | Donor lymphocytes | - | - | - | - | 1件: 28 28 |
542 | Donor mesenchymal stem cell infusions | - | - | - | - | 1件: 36 36 |
543 | Donor peripheral blood stem cells. | - | - | - | - | 1件: 65 65 |
544 | DopaFuse Delivery System | - | - | - | - | 1件: 6 6 |
545 | Dopamina | 1件: Dopamine Dopamine | 1件: D07870
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 299 299 |
546 | Dopamine | 1件: Dopamine Dopamine | 1件: D07870
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 7, 74 |
547 | Dopamine Agent | 1件: Dopamine Dopamine | 1件: D07870
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
548 | Dopamine agonist treatment | 1件: Dopamine Dopamine | 1件: D07870
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 74 74 |
549 | Dopamine Agonists | 1件: Dopamine Dopamine | 1件: D07870
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 74 74 |
550 | Dopamine Agonists (pramipexole, ropirinole) | 2件: Dopamine Dopamine, Pramipexole | 2件: D05575
D05575
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
551 | Dopaminergic Agonist + Apomorphine | 1件: Apomorphine Apomorphine | 1件: D07460
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
552 | Dopaminergic Agonists | - | - | - | - | 1件: 6 6 |
553 | DOPS | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 17 |
554 | Doptelet | 1件: Avatrombopag Avatrombopag | 1件: D10306
D10306
| 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 63 63 |
555 | Doptelet 20 mg film-coated tablets | 1件: Avatrombopag Avatrombopag | 1件: D10306
D10306
| 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 63 63 |
556 | Doravirine | 1件: Doravirine Doravirine | 1件: D10624
D10624
| - | - | 1件: 265 265 |
557 | Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO] | 3件: Doravirine Doravirine, Tenofovir, Tenofovir disoproxil | 2件: D06074
D06074
,
D10624
| - | - | 1件: 265 265 |
558 | DORIBAX | 1件: Doripenem Doripenem | 1件: D03895
D03895
| - | - | 1件: 299 299 |
559 | Doripenem | 1件: Doripenem Doripenem | 1件: D03895
D03895
| - | - | 1件: 299 299 |
560 | DORIPENEM HYDRATE | 1件: Doripenem Doripenem | 1件: D03895
D03895
| - | - | 1件: 299 299 |
561 | Dornase alfa | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 2件: 53 53, 299 |
562 | Dornase alfa (Pulmozyme) | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
563 | Dornase alfa [Pulmozyme®] | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
564 | Dornase alpha | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
565 | Dorzolamide | 1件: Dorzolamide Dorzolamide | 1件: D07871
D07871
| 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 | 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 90 90 |
566 | Dosage of cytokines | - | - | - | - | 1件: 50 50 |
567 | Dose level 1 | - | - | - | - | 1件: 46 46 |
568 | Dose level 2 | - | - | - | - | 1件: 46 46 |
569 | Dose level 3 | - | - | - | - | 1件: 46 46 |
570 | Dose level 4 | - | - | - | - | 1件: 46 46 |
571 | Dose of 60 mg/kg alpha1-proteinase inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 |
572 | Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 |
573 | Dose-Establishing Study 1 Niacin 250mg | 1件: Niacin Niacin | 1件: D00049
D00049
| - | - | 1件: 78 78 |
574 | Dose-Establishing Study 1 Niacin 500mg | 1件: Niacin Niacin | 1件: D00049
D00049
| - | - | 1件: 78 78 |
575 | Dose-Establishing Study 2 Niacin 500mg | 1件: Niacin Niacin | 1件: D00049
D00049
| - | - | 1件: 78 78 |
576 | Dosing Extension | - | - | - | - | 1件: 113 113 |
577 | Dosing Interruption of Natalizumab | 1件: Natalizumab Natalizumab | 1件: D06886
D06886
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
578 | DOSTINEX | 1件: Cabergoline Cabergoline | 1件: D00987
D00987
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 75 75 |
579 | DOTANOC | - | - | - | - | 1件: 84 84 |
580 | Dotarem | 1件: Gadoteric acid Gadoteric acid | 1件: D08007
D08007
| - | - | 1件: 13 13 |
581 | Dotarem 0,5mmol/ml, | 1件: Gadoteric acid Gadoteric acid | 1件: D08007
D08007
| - | - | 1件: 13 13 |
582 | Dotatate | 1件: Dotatate Dotatate | - | - | - | 1件: 84 84 |
583 | Double Dose | - | - | - | - | 2件: 38 38, 162 |
584 | Double-blind Abatacept | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 |
585 | Double-blind adalimumab | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 107 |
586 | Double-Blind Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 51 51 |
587 | Doxazosin | 1件: Doxazosin Doxazosin | 1件: D07874
D07874
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 57 57, 67 |
588 | Doxepin | 1件: Doxepin Doxepin | 1件: D07875
D07875
| 3件: HRH1 HRH1, SLC6A2, SLC6A4 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
589 | Doxepin and Zopiclone | 2件: Doxepin Doxepin, Zopiclone | 2件: D01372
D01372
,
D07875
| 19件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, SLC6A2, SLC6A4 💬 | 10件: Calcium signaling pathway Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction 💬 | 1件: 6 6 |
590 | Doxil | - | - | - | - | 1件: 63 63 |
591 | Doxorubicin | 1件: Doxorubicin Doxorubicin | 1件: D03899
D03899
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 5件: 26 26, 28, 34, 65, 331 |
592 | Doxorubicin Hydrochloride | 1件: Doxorubicin Doxorubicin | 1件: D03899
D03899
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 3件: 26 26, 34, 331 |
593 | Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase | 4件: Asparaginase Escherichia coli Asparaginase Escherichia coli, Cyclophosphamide, Doxorubicin, Methotrexate | 4件: D00142
D00142
,
D00287
,
D03899
,
D07760
| 4件: DHFR DHFR, DHFR2, TOP2A, TOP2B 💬 | 6件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬 | 1件: 65 65 |
594 | Doxy | - | - | - | - | 1件: 34 34 |
595 | Doxycyclin | 1件: Doxycycline Doxycycline | 2件: D00307
D00307
,
D07876
| - | - | 2件: 97 97, 299 |
596 | Doxycycline | 1件: Doxycycline Doxycycline | 2件: D00307
D00307
,
D07876
| - | - | 17件: 13 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
597 | Doxycycline 100 mg Capsules | 1件: Doxycycline Doxycycline | 2件: D00307
D00307
,
D07876
| - | - | 1件: 89 89 |
598 | Doxycycline 100-200mg capsules daily for 6 months | 1件: Doxycycline Doxycycline | 2件: D00307
D00307
,
D07876
| - | - | 1件: 167 167 |
599 | DOXYCYCLINE HYCLATE | 1件: Doxycycline Doxycycline | 2件: D00307
D00307
,
D07876
| - | - | 3件: 23 23, 96, 227 |
600 | Doxycycline Hyclate Ph.Eur | 1件: Doxycycline Doxycycline | 2件: D00307
D00307
,
D07876
| - | - | 1件: 167 167 |
601 | Doxycycline Injection [Doxy] | 1件: Doxycycline Doxycycline | 2件: D00307
D00307
,
D07876
| - | - | 1件: 34 34 |
602 | Doxycycline Tablets | 1件: Doxycycline Doxycycline | 2件: D00307
D00307
,
D07876
| - | - | 1件: 46 46 |
603 | DoxyHEXAL® tabs 100 mg Tabletten | - | - | - | - | 1件: 28 28 |
604 | DP Mannitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
605 | DPA | - | - | - | - | 5件: 2 2, 6, 13, 85, 127 |
606 | DPA-714 PET/MRI | - | - | - | - | 1件: 13 13 |
607 | DPA-714-PET/MRI | - | - | - | - | 1件: 6 6 |
608 | DPPG | - | - | - | - | 1件: 79 79 |
609 | Dr. Reddy’s Rituximab (DRL_RI) 100mg | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
610 | Dr. Reddy’s Rituximab (DRL_RI) 500mg | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
611 | Dried blood spot (DBS) sampling | - | - | - | - | 1件: 19 19 |
612 | Drisapersen | 1件: Drisapersen Drisapersen | 1件: D10114
D10114
| 1件: DMD DMD 💬 | 4件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 |
613 | DRISAPERSEN SODIUM | 1件: Drisapersen Drisapersen | 1件: D10114
D10114
| 1件: DMD DMD 💬 | 4件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 |
614 | DRL_RI | - | - | - | - | 1件: 46 46 |
615 | Dronabinol | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 5件: 2 2, 13, 46, 271, 298 |
616 | Dronabinol 25 mg/ml, oral drops | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 |
617 | Dronabinol capsule 2,5 mg | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 |
618 | Dronabinol capsule 2.5. mg | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 46 46, 271 |
619 | Drops | - | - | - | - | 2件: 50 50, 107 |
620 | Droxidopa | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 5 5, 6, 17, 169, 170 |
621 | Droxidopa 100 MG [Northera] | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
622 | Drug - SHR1459 | - | - | - | - | 1件: 13 13 |
623 | Drug free, IS monotherapy and GC combined with IS | - | - | - | - | 1件: 300 300 |
624 | Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom | - | - | - | - | 2件: 46 46, 49 |
625 | Drug protocol | - | - | - | - | 1件: 46 46 |
626 | Drug treatment | - | - | - | - | 3件: 51 51, 74, 271 |
627 | Drug-Carbamazepine (Tegretol XR) | 1件: Carbamazepine Carbamazepine | 1件: D00252
D00252
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 231 231 |
628 | Drug: | - | - | - | - | 3件: 14 14, 46, 113 |
629 | DRX005B | - | - | - | - | 1件: 19 19 |
630 | Dry powder tobramycin | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
631 | DS-1211b | - | - | - | - | 1件: 166 166 |
632 | DS-2325a | - | - | - | - | 1件: 160 160 |
633 | DS-5141b | - | - | - | - | 1件: 113 113 |
634 | DS-7011a | - | - | - | - | 1件: 49 49 |
635 | DSG3-CAART | - | - | - | - | 1件: 35 35 |
636 | DT-216 | - | - | - | - | 1件: 18 18 |
637 | DTG Tablet | - | - | - | - | 1件: 256 256 |
638 | DTPA | 1件: Pentetic acid Pentetic acid | 1件: D05422
D05422
| - | - | 2件: 28 28, 299 |
639 | DTR Melatonin (NIH CC PDS) | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 202 202 |
640 | DTX301 | - | - | - | - | 1件: 251 251 |
641 | Dual release hydrocortisone (plenadren) | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
642 | Dual-therapy | - | - | - | - | 1件: 50 50 |
643 | Dukoral | 1件: Recombinant Cholera Toxin B Subunit Recombinant Cholera Toxin B Subunit | - | - | - | 1件: 97 97 |
644 | Dulaglutide | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 299 299 |
645 | Dulaglutide 0.75Mg/0.5Ml Inj Pen | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 299 299 |
646 | Duloxetine | 1件: Duloxetine Duloxetine | 1件: D07880
D07880
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 |
647 | Duloxetine hydrochloride | 1件: Duloxetine Duloxetine | 1件: D07880
D07880
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
648 | Duloxetine Hydrochloride (HCI) | 1件: Duloxetine Duloxetine | 1件: D07880
D07880
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 13 13 |
649 | Dummy Qing Re Huo Xue (QRHX) | - | - | - | - | 1件: 46 46 |
650 | Duo-Therapy with Sildenafil + Bosentan | 2件: Bosentan Bosentan, Sildenafil | 3件: D01227
D01227
,
D07538
,
D08514
| 3件: EDNRA EDNRA, EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
651 | DUOC-01 | - | - | - | - | 3件: 13 13, 19, 20 |
652 | DUODOPA | - | - | - | - | 1件: 6 6 |
653 | Duodopa gel intestinale | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
654 | Duodopa intestinal gel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
655 | Duodopa intestinalgel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
656 | Duodopa LD/CD 20/5 mg/mL | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
657 | Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
658 | Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
659 | DUODOPA®Intestinal Gel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
660 | Dupilumab | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 5件: 51 51, 97, 98, 160, 162 |
661 | Dupilumab (blinded) | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 98 98 |
662 | Dupilumab (open-label) | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 98 98 |
663 | Dupilumab 300Mg Solution for Injection | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 51 51 |
664 | Dupilumab Injection | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 160 160 |
665 | Dupilumab Prefilled Syringe | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 160 160 |
666 | Dupixent | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 3件: 98 98, 160, 162 |
667 | DUR-928 | - | - | - | - | 1件: 94 94 |
668 | DURAMYCIN | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
669 | Duramycin, 2622U90 | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
670 | Durvalumab | 1件: Durvalumab Durvalumab | 1件: D10808
D10808
| 1件: CD274 CD274 💬 | 2件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | 1件: 85 85 |
671 | Dutasterida | 1件: Dutasteride Dutasteride | 1件: D03820
D03820
| 2件: SRD5A1 SRD5A1, SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 1件: 2 2 |
672 | Dutasteride | 1件: Dutasteride Dutasteride | 1件: D03820
D03820
| 2件: SRD5A1 SRD5A1, SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 2件: 1 1, 2 |
673 | Duvoglustat | 1件: Duvoglustat Duvoglustat | 1件: D09605
D09605
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
674 | Duvoglustat HCl | 1件: Duvoglustat Duvoglustat | 1件: D09605
D09605
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
675 | Duvoglustat hydrochloride | 1件: Duvoglustat Duvoglustat | 1件: D09605
D09605
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
676 | DW1809 | - | - | - | - | 1件: 46 46 |
677 | DW1809-1 | - | - | - | - | 1件: 46 46 |
678 | DW1809-T2 | - | - | - | - | 1件: 46 46 |
679 | DWN12088 | - | - | - | - | 1件: 85 85 |
680 | DWP422 25mg | - | - | - | - | 1件: 46 46 |
681 | DX-890 | - | - | - | - | 1件: 299 299 |
682 | DYDROGESTERONE | 1件: Dydrogesterone Dydrogesterone | 1件: D01217
D01217
| 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 |
683 | DYN101 | - | - | - | - | 1件: 111 111 |
684 | Dynacirc CR (Isradipine) | 1件: Isradipine Isradipine | 1件: D00349
D00349
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
685 | DYNE-101 | - | - | - | - | 1件: 113 113 |
686 | DYNE-251 | - | - | - | - | 1件: 113 113 |
687 | Dyphenhydramine hydrochloride | - | - | - | - | 1件: 63 63 |
688 | Dysport | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 2件: 13 13, 36 |
689 | DYSPORT*SC IM 2FL 500U | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 |
690 | DYSPORT® | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 |
691 | Dysport® (Botulinumtoxin A (Btx A)) | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 36 36 |
692 | DZP | - | - | - | - | 1件: 49 49 |
693 | Désogestrel | 1件: Desogestrel Desogestrel | 1件: D02367
D02367
| 2件: ESR1 ESR1, PGR 💬 | 11件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 230 230 |